Chemical Component Summary

Name4-[4-({[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
Identifiers4-[4-[(5-tert-butyl-2-quinolin-6-yl-pyrazol-3-yl)carbamoylamino]-3-fluoro-phenoxy]-N-methyl-pyridine-2-carboxamide
FormulaC30 H28 F N7 O3
Molecular Weight553.59
TypeNON-POLYMER
Isomeric SMILESCNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3c4ccc5ncccc5c4)C(C)(C)C)c(F)c2)ccn1
InChIInChI=1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40)
InChIKeyWVXNSAVVKYZVOE-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count69
Chiral Atom Count0
Bond Count73
Aromatic Bond Count29

Drug Info: DrugBank

DrugBank IDDB13005 
NameRebastinib
Groupsinvestigational
DescriptionRebastinib has been used in trials studying the treatment of Chronic Myeloid Leukemia. It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent.
Synonyms
  • Rebastinib tosylate
  • Rebastinib
Categories
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Heterocyclic Compounds, Fused-Ring
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive, drug therapy
  • Protein Kinase Inhibitors
CAS number1020172-07-9